FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost. NYT > Health
Tag: Leqembi
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai and Biogen shows. U.S. News